At cellvie, we are pioneering Therapeutic Mitochondria Transplantation, a novel treatment approach aimed at the cellular energy metabolism.
Location: United States, Texas, Houston
Employees: 1-10
Total raised: $5.5M
Founded date: 2018
Investors 1
| Date | Name | Website |
| 27.07.2023 | Taiho Vent... | taihoventu... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.02.2023 | - | $5.5M | - |
Mentions in press and media 20
| Date | Title | Description |
| 08.11.2024 | Bio-Europe: Switzerland's Biotech Showcase in Stockholm | The heart of Europe beats strong in Stockholm this November. Bio-Europe, the continent's premier partnering event for the life sciences, is back for its 30th edition. This year, it promises to be a melting pot of innovation, collaboration, ... |
| 05.11.2024 | Bio Europe in Stockholm hosts 33 Swiss companies | Currently in its 30-year-edition, BIO-Europe remains Europe's leading partnering event, for the life sciences ecosystem, providing an exceptional opportunity to explore the latest trends learn and connect with potential partners. The past ... |
| 31.05.2024 | Swiss life science startups headed for San Diego | The BIO International Convention 2024, taking place in San Diego from 3 to 6 June, is the largest global biotechnology event with over 20,000 industry leaders from around the world attending. The target group includes representatives from ... |
| 06.11.2023 | A decent representation at BIO-Europe | |
| 05.06.2023 | A significant number of Swiss biotechs exhibit in Boston | |
| 10.05.2023 | Leadership changes in startups' C-Suites | |
| 07.02.2023 | Zurich -based biotechnology startup Cellvie raises USD 5.5 million in funding | HOUSTON and ZURICH, February 6, 2023, Towards the end of 2023, cellvie Inc., a pioneer in the Harvard-developed Therapeutic Mitochondria Transplantation (TMT) method, closes a USD 5.5 Million funding. |
| 06.02.2023 | Biotech startup cellvie gets USD 5.5 million to develop treatments for mitochondria dysfunction | Biotech startup cellvie gets USD 5.5 million to develop treatments for mitochondria dysfunction 06.02.2023 16:45, Morgane Ghilardi linkedIn facebook twitter instagram youtube --> The Harvard spin-off, which is a leader in therapeutic mit... |
| 06.02.2023 | cellvie Raises $5.5M in Financing | cellvie Inc., a Zurich, Switzerland- and Houston, TX-based Therapeutic Mitochondria Transplantation (TMT) company, closed a $5.5M financing. The round was led by Taiho Ventures, with participation from existing investors Kizoo Technology Ca... |
| 06.02.2023 | $5.5 million for cellvie |
Show more